ARCT
Arcturus Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.46 / 10
Netural
Sentiment is neutral (5.46) with a strong fund‑flow rating of 7.59; inflow ratios hover around 0.48 but trends are negative across all investor sizes. Analyst consensus: 2 Strong Buy, 1 Buy, 1 Neutral, reflecting mixed confidence. Caution recommended.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
25%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-18
InstitutionB. Riley Securities
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of ARCT?
- ARCT holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.46/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
